A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI) — Stella
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
(5 sites) United States
UCLA Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, California Children's Hospital of Orange County, Orange, California Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois Children's Hospital of LSU Health Sciences Center Shreveport, Shreveport, Louisiana West Virginia University Medicine Children's Hospital, Morgantown, West Virginia
Key details Sponsor
Tetraphase Pharmaceuticals, Inc
Collaborators
Innoviva Specialty Therapeutics
Enrollment target
~35 participants
Primary completion
February 2029
Last updated October 2025